The latest price target for Alkermes (NASDAQ:ALKS) was reported by Goldman Sachs on February 14, 2025. The analyst firm set a price target for $32.00 expecting ALKS to fall to within 12 months (a possible -9.40% downside). 26 analyst firms have reported ratings in the last year.

The latest analyst rating for Alkermes (NASDAQ:ALKS) was provided by Goldman Sachs, and Alkermes maintained their buy rating.

The last upgrade for Alkermes PLC happened on November 5, 2024 when Stifel raised their price target to $36. Stifel previously had a hold for Alkermes PLC.

The last downgrade for Alkermes PLC happened on February 20, 2024 when UBS changed their price target from $25 to $25 for Alkermes PLC.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alkermes, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alkermes was filed on February 14, 2025 so you should expect the next rating to be made available sometime around February 14, 2026.

While ratings are subjective and will change, the latest Alkermes (ALKS) rating was a maintained with a price target of $30.00 to $32.00. The current price Alkermes (ALKS) is trading at is $35.32, which is out of the analyst’s predicted range.